USPTO Patent Application: Modified Release Minoxidil for Hair Loss
Summary
The USPTO has published a patent application (US20260083738A1) detailing modified release minoxidil oral formulations for treating hair loss. The application, filed by Reid Waldman, describes compositions including minoxidil alone or with other active agents, and methods of treatment. This represents a new patent filing for a potential pharmaceutical product.
What changed
This document is a USPTO patent application (US20260083738A1) for modified release oral formulations of minoxidil, intended for treating hair loss. The application, filed on December 1, 2025, by inventor Reid Waldman, covers pharmaceutical compositions containing minoxidil or its salts, potentially combined with other active agents, as well as methods of use and kits. This filing indicates a new development in the intellectual property landscape for hair loss treatments.
As this is a patent application, it does not impose immediate regulatory obligations on pharmaceutical companies or healthcare providers. However, it signals potential future market exclusivity for the applicant if the patent is granted. Companies involved in hair loss treatments or minoxidil formulations should monitor this application's progress and consider its implications for their own product development and intellectual property strategies.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
Application US20260083738A1 Kind: A1 Mar 26, 2026
Inventors
Reid WALDMAN
Abstract
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.
CPC Classifications
A61K 31/506 A61K 9/0053 A61K 9/2013 A61K 9/2018 A61K 9/2054 A61K 9/28 A61P 17/14
Filing Date
2025-12-01
Application No.
19404931
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.